Literature DB >> 30145452

Investigation of the thermal shift assay and its power to predict protein and virus stabilizing conditions.

Dora Sviben1, Branimir Bertoša2, Andrea Hloušek-Kasun2, Dubravko Forcic1, Beata Halassy1, Marija Brgles3.   

Abstract

Protein thermal shift assay (TSA) has been extensively used in investigation of protein stabilization (for protein biopharmaceutics stabilization, protein crystallization studies or screening of recombinant proteins) and drug discovery (screening of ligands or inhibitors). This work aimed to analyze thermal shift assay results in comparison to protein polymerization (multimerization and aggregation) propensity and test the most stabilizing formulations for their stabilization effect on enveloped viruses. Influence of protein concentration, buffer pH and molarity was tested on three proteins (immunoglobulin G, ovalbumin, and albumin) and results showed that each of these factors has an impact on determined shift in protein melting point Tm, and the impact was similar for all three proteins. In case of ovalbumin, molecular dynamics simulations were performed with the goal to understanding molecular basis of protein's thermal stability dependence on pH. Effect of three denaturing agents in a wide concentration range on Tm showed nicely that chemical denaturation occurs only at the highest concentrations. Results showed similar effect on Tm for most formulations on different proteins. Most successful formulations were tested for enveloped virus stabilizing potential using cell culture infectivity assay (CCID50) and results showed lack of correlation with TSA results. Only weak correlation of Tm shift and protein polymerization measured by SEC-HPLC was obtained, meaning that polymerization cannot be predicted from Tm shifts.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biopharmaceutics; Excipients; Protein aggregation; Thermal shift assay; Virus stability

Mesh:

Substances:

Year:  2018        PMID: 30145452     DOI: 10.1016/j.jpba.2018.08.017

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  5 in total

1.  Quality-Related Properties of Equine Immunoglobulins Purified by Different Approaches.

Authors:  Sanja Mateljak Lukačević; Tihana Kurtović; Maja Lang Balija; Marija Brgles; Stephanie Steinberger; Martina Marchetti-Deschmann; Beata Halassy
Journal:  Toxins (Basel)       Date:  2020-12-14       Impact factor: 4.546

2.  The Antileukemic Effect of Xestoquinone, A Marine-Derived Polycyclic Quinone-Type Metabolite, Is Mediated through ROS-Induced Inhibition of HSP-90.

Authors:  Kuan-Chih Wang; Mei-Chin Lu; Kai-Cheng Hsu; Mohamed El-Shazly; Shou-Ping Shih; Ssu-Ting Lien; Fu-Wen Kuo; Shyh-Chyun Yang; Chun-Lin Chen; Yu-Chen S H Yang
Journal:  Molecules       Date:  2021-11-21       Impact factor: 4.411

3.  Hydroxamate and thiosemicarbazone: Two highly promising scaffolds for the development of SARS-CoV-2 antivirals.

Authors:  Yin-Sui Xu; Jia-Zhu Chigan; Jia-Qi Li; Huan-Huan Ding; Le-Yun Sun; Lu Liu; Zhenxin Hu; Ke-Wu Yang
Journal:  Bioorg Chem       Date:  2022-04-18       Impact factor: 5.307

4.  Roughness of Production Conditions: Does It Really Affect Stability of IgG-Based Antivenoms?

Authors:  Sanja Mateljak Lukačević; Tihana Kurtović; Juraj Borić; Beata Halassy
Journal:  Toxins (Basel)       Date:  2022-07-13       Impact factor: 5.075

5.  Differential effects of 'resurrecting' Csp pseudoproteases during Clostridioides difficile spore germination.

Authors:  M Lauren Donnelly; Emily R Forster; Amy E Rohlfing; Aimee Shen
Journal:  Biochem J       Date:  2020-04-30       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.